Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cardiovascular Disorders
Published in: BMC Cardiovascular Disorders 1/2021

Open Access 01-12-2021 | Aortic Aneurysm | Case report

Custom-made fenestrated stent for mycotic aortic aneurysms: a report of two cases

Authors: Siting Li, Mengyin Chen, Yuehong Zheng, Zhili Liu, Rong Zeng

Published in: BMC Cardiovascular Disorders | Issue 1/2021

Login to get access

Abstract

Background

Mycotic aortic aneurysm is a rare and potentially life-threatening lesion, and endovascular repair has become increasingly accepted for intervention. Fenestrated endografts are available options to treat aneurysms involving visceral arteries. Here, we first report two patients with mycotic aortic aneurysm involving paraviscereal aorta who were successfully treated with custom-made fenestrated endograft.

Case presentation

Two patients were presented with mycotic aortic aneurysm. Due to their comorbidities and the involvement of the renal arteries, company-manufactured fenestrated stents were designed. Meanwhile, antibiotic therapy was administrated for 2 months before endovascular repair. Patients improved well without complications.

Conclusions

Custom-made fenestrated endovascular stent is an effective and feasible alternative solution to mycotic paravisceral aorta aneurysm.
Literature
1.
Huang YK, Chen CL, Lu MS, Tsai FC, Lin PL, Wu CH, et al. Clinical, microbiologic, and outcome analysis of mycotic aortic aneurysm: the role of endovascular repair. Surg Infect. 2014;15(3):290–8.CrossRef
2.
Semba CP, Sakai T, Slonim SM, Razavi MK, Kee ST, Jorgensen MJ, et al. Mycotic aneurysms of the thoracic aorta: repair with use of endovascular stent-grafts. J Vasc Intervent Radiol JVIR. 1998;9(1 Pt 1):33–40.CrossRef
3.
Sörelius K, Wanhainen A, Furebring M, Björck M, Gillgren P, Mani K. Nationwide study of the treatment of mycotic abdominal aortic aneurysms comparing open and endovascular repair. Circulation. 2016;134(23):1822–32.CrossRef
4.
Sörelius K, Budtz-Lilly J, Mani K, Wanhainen A. Systematic review of the management of mycotic aortic aneurysms. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg. 2019;58(3):426–35.CrossRef
5.
Sörelius K, Mani K, Björck M, Sedivy P, Wahlgren CM, Taylor P, et al. Endovascular treatment of mycotic aortic aneurysms: a European multicenter study. Circulation. 2014;130(24):2136–42.CrossRef
6.
Early results. of fenestrated endovascular repair of juxtarenal aortic aneurysms in the United Kingdom. Circulation. 2012;125(22):2707–15.
7.
Verhoeven EL, Vourliotakis G, Bos WT, Tielliu IF, Zeebregts CJ, Prins TR, et al. Fenestrated stent grafting for short-necked and juxtarenal abdominal aortic aneurysm: an 8-year single-centre experience. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg. 2010;39(5):529–36.CrossRef
8.
Sörelius K, Wanhainen A, Wahlgren CM, Langenskiöld M, Roos H, Resch T, et al. Nationwide Study on Treatment of Mycotic Thoracic Aortic Aneurysms. European journal of vascular endovascular surgery: the official journal of the European Society for Vascular Surgery. 2019;57(2):239–46.CrossRef
9.
Gallitto E, Faggioli G, Pini R, Mascoli C, Ancetti S, Fenelli C, et al. Endovascular repair of thoraco-abdominal aortic aneurysms by fenestrated and branched endografts†. European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery. 2019;56(5):993–1000.CrossRef
10.
de Niet A, Zeebregts CJ, Reijnen M. Outcomes after treatment of complex aortic abdominal aneurysms with the fenestrated Anaconda endograft. J Vasc Surg. 2020;72(1):25–35.e1.CrossRef
11.
Sule JA, Dharmaraj RB. Surgeon Modified Fenestrated Endovascular Abdominal Aortic Repair (F-EVAR) for Subacute Multifocal Mycotic Abdominal and Iliac Artery Saccular Aneurysms. EJVES short reports. 2016;32:7–11.CrossRef
12.
Durgin JM, Arous EJ, Kumar S, Robinson WP 3rd, Simons JP, Schanzer A. Complete regression of a symptomatic, mycotic juxtarenal abdominal aortic aneurysm after treatment with fenestrated endovascular aneurysm repair. J Vasc Surg. 2016;64(3):803–6.CrossRef
13.
Okugi S, Azuma T, Yokoi Y, Domoto S, Niinami H. Therapeutic Strategies for Infectious Multiple Aortic Aneurysms: Thoracoabdominal Aortic Aneurysm Treatment Using a Fenestrated Stent-Graft. Annals of vascular diseases. 2020;13(3):326–9.CrossRef
14.
Dossabhoy SS, Simons JP, Flahive JM, Aiello FA, Sheth P, Arous EJ, et al. Fenestrated endovascular aortic aneurysm repair using physician-modified endovascular grafts versus company-manufactured devices. J Vasc Surg. 2018;67(6):1673–83.CrossRef
15.
Motta F, Vallabhaneni R, Kalbaugh CA, Alyateem G, Marston WA, Farber MA. Comparison of commercially available versus customized branched-fenestrated devices in the treatment of complex aortic aneurysms. J Vasc Surg. 2019;69(3):645–50.CrossRef
16.
Sénémaud JN, Ben Abdallah I, de Boissieu P, Touma J, Kobeiter H, Desgranges P, et al. Intraoperative adverse events and early outcomes of custom-made fenestrated stent grafts and physician-modified stent grafts for complex aortic aneurysms. J Vasc Surg. 2020;71(6):1834-42.e1.CrossRef
17.
Oderich GS, Ribeiro MS, Sandri GA, Tenorio ER, Hofer JM, Mendes BC, et al. Evolution from physician-modified to company-manufactured fenestrated-branched endografts to treat pararenal and thoracoabdominal aortic aneurysms. J Vasc Surg. 2019;70(1):31–42.e7.CrossRef
18.
Clough RE, Topple JA, Zayed HA, Lyons OT, Carrell TW, Taylor PR. Endovascular repair of a tuberculous mycotic thoracic aortic aneurysm with a custom-made device. J Vasc Surg. 2010;51(5):1272–5.CrossRef
Metadata
Title
Custom-made fenestrated stent for mycotic aortic aneurysms: a report of two cases
Authors
Siting Li
Mengyin Chen
Yuehong Zheng
Zhili Liu
Rong Zeng
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2021
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-021-02234-9

Other articles of this Issue 1/2021

BMC Cardiovascular Disorders 1/2021 Go to the issue

Research article

Current knowledge of Chagas-related heart disease among pediatric cardiologists in the United States

Research

Platelet-to-hemoglobin ratio as a valuable predictor of long-term all-cause mortality in coronary artery disease patients with congestive heart failure

Research article

Cardiovascular risk in patients with and without diabetes presenting with chronic coronary syndrome in 2004–2016

Correction

Correction to: Selenium supplementation in patients with peripartum cardiomyopathy: a proof‑of‑concept trial

Study protocol

Pediatric In-Hospital Cardiac Arrest International Registry (PACHIN): protocol for a prospective international multicenter register of cardiac arrest in children

Research article

The potential regulatory role of hsa_circ_0004104 in the persistency of atrial fibrillation by promoting cardiac fibrosis via TGF-β pathway

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits